AXLA - Axcella Health Inc.
Close
4.58
-0.900 -19.651%
Share volume: 41,958
Last Updated: Wed 22 Nov 2023 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.48
-0.90
-16.42%
Summary score
22%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.45%
Return on assets
-13.98%
Return on sales
0%
Return on invested capital
227.89%
Total debt ratio
33.23%
Debt ratio change over timeo
-0.85%
Current Ratio
13.75%
Quick Ratio
0%
Cash Position Ratio
13.36%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-21.78%
Return on assets
-13.81%
Return on sales
0%
Return on invested capital
209.28%
Total debt ratio
31.83%
Debt ratio change over timeo
-0.83%
Current Ratio
14.02%
Quick Ratio
0%
Cash Position Ratio
13.6%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.01%
Return on assets
-9.76%
Return on sales
0%
Return on invested capital
258.83%
Total debt ratio
26.13%
Debt ratio change over time
-0.8%
Current Ratio
22.66%
Quick Ratio
0%
Cash Position Ratio
21.6%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.96%
Return on assets
-106.47%
Return on sales
0%
Return on invested capital
5.28%
Total debt ratio
-85.19%
Debt ratio change over time
-0.85%
Current Ratio
6.2%
Quick Ratio
0%
Cash Position Ratio
5.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AXLA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -22.45% | -3.65% | 12.3% | 6.42% |
| Return on assets | -13.98% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 227.89% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 33.23% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.85% | 224.03% | 6.03% | 1.46% |
| Dept financing | 8% | 50% | 19% | 8% |
| Current Ratio | 14.02% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 13.6% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 14% | 32% | 33% |
| Short-term ratios | AXLA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.78% | -16.17% | 18.05% | 7.63% |
| Return on assets | -13.81% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 209.28% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 69% | 62% |
| Total debt ratio | 31.83% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.83% | 851.68% | 10.97% | 0.58% |
| Dept financing | 8% | 50% | 21% | 8% |
| Current Ratio | 14.02% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 13.6% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 23% | 18% | 34% |